<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     naa a22        4500</leader>
  <controlfield tag="001">510742742</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180411083033.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">180411e20130601xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s12630-013-9915-9</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s12630-013-9915-9</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Conscious sedation for awake fibreoptic intubation: a review of the literature</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Kevin Johnston, Mridula Rai]</subfield>
  </datafield>
  <datafield tag="246" ind1="1" ind2=" ">
   <subfield code="a">La sédation consciente pour l'intubation fibroscopique vigile</subfield>
   <subfield code="b">revue de la littérature</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Purpose: Awake fibreoptic intubation (AFOI) is the gold standard of management of the predicted difficult airway. Sedation is frequently used to make the process more tolerable to patients. It is not always easy to strike a balance between patient comfort and good intubating conditions on the one hand and maintaining ventilation and a patent airway on the other. In the last 30years, many drugs and drug combinations have been described, but there is very little in the literature to help guide the practitioner to choose between them. The objective of this article is to discuss the evidence supporting the use of the agents described with regard to their efficacy, recommended doses and techniques, and limitations to their use for AFOI. Source: Publication databases were searched for articles published from 1996 to 2012 relating to sedation for AFOI. Principle findings: Benzodiazepines, propofol, opioids, alpha2-adrenoceptor agonists, and ketamine are the main classes of drugs that have been described to facilitate AFOI. Drugs that are most suitable have a combination of both anxiolytic and analgesic properties. The ideal choice of drug may vary depending on the patient and the indication for AFOI. Conclusion: There is good evidence to support the use of two drugs in particular, remifentanil and dexmedetomidine. Each has certain unique characteristics that make them an attractive choice for an AFOI.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Canadian Anesthesiologists' Society, 2013</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Johnston</subfield>
   <subfield code="D">Kevin</subfield>
   <subfield code="u">Department of Anesthesia, Leeds General Infirmary, Great George Street, LS1 3EX, Leeds, UK</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Rai</subfield>
   <subfield code="D">Mridula</subfield>
   <subfield code="u">Nuffield Department of Anesthetics, John Radcliffe Hospital, Oxford, UK</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Canadian Journal of Anesthesia/Journal canadien d'anesthésie</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">60/6(2013-06-01), 584-599</subfield>
   <subfield code="x">0832-610X</subfield>
   <subfield code="q">60:6&lt;584</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">60</subfield>
   <subfield code="o">12630</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s12630-013-9915-9</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s12630-013-9915-9</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Johnston</subfield>
   <subfield code="D">Kevin</subfield>
   <subfield code="u">Department of Anesthesia, Leeds General Infirmary, Great George Street, LS1 3EX, Leeds, UK</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Rai</subfield>
   <subfield code="D">Mridula</subfield>
   <subfield code="u">Nuffield Department of Anesthetics, John Radcliffe Hospital, Oxford, UK</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Canadian Journal of Anesthesia/Journal canadien d'anesthésie</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">60/6(2013-06-01), 584-599</subfield>
   <subfield code="x">0832-610X</subfield>
   <subfield code="q">60:6&lt;584</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">60</subfield>
   <subfield code="o">12630</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
